Advair
-
Advair 50mcg/500mcg
1 pack
50mcg/500mcg$44.96$44.96
per item+ FREE BONUS PILLS -
Advair 50mcg/250mcg
1 pack
50mcg/250mcg$38.66$38.66
per item+ FREE BONUS PILLS -
Advair 50mcg/100mcg
1 pack
50mcg/100mcg$34.02$34.02
per item+ FREE BONUS PILLS -
Advair 25mcg/250mcg
1 inhaler
25mcg/250mcg$49.46$49.46
per item+ FREE BONUS PILLS -
2 inhalers
25mcg/250mcg$86.40$12.51
saving$43.20
per item+ FREE BONUS PILLS -
Advair 25mcg/125mcg
1 inhaler
25mcg/125mcg$35.96$35.96
per item+ FREE BONUS PILLS -
2 inhalers
25mcg/125mcg$64.26$7.65
saving$32.13
per item+ FREE BONUS PILLS -
Advair 25mcg/50mcg
1 inhaler
25mcg/50mcg$29.66$29.66
per item+ FREE BONUS PILLS -
2 inhalers
25mcg/50mcg$49.50$9.81
saving$24.75
per item+ FREE BONUS PILLS
Bonus Policy
- 4 free bonus pills for all orders!
- Order 3 or more products and get free Regular Airmail (12-21 days) shipping!
- Free Shipping for orders starting with $300.00!
- Free insurance (guaranteed reshipment if delivery failed) for orders starting with $200.00!
Description
Advair (generic name: Fluticasone / Salmeterol; brand names include: Seroflo / Seretide / Viani / Adoair / ForAiris) is a combination of two medicines (fluticasone and salmeterol) that are used to help control the symptoms of asthma and improve lung function.
Advair is available as:
1. Packs consisting of 30 capsules (rotacaps) each and a rotahaler (a plastic inhalation device).
one pack = 30 rotacaps + rotahaler
2. Inhalers - diskus inhalation devices (120 MDI each).
Advair is indicated for:
maintenance treatment of asthma in patients 4 years of age and older;
maintenance treatment of airflow obstruction and reducing exacerbations (a marked worsening of COPD symptoms) in patients with chronic obstructive pulmonary disease (COPD).
Advair treats both main causes of asthma symptoms, airway constriction and inflammation, to help prevent them from occurring in the first place.
Advair is the only COPD product that contains an anti-inflammatory and a long-acting bronchodilator working together to help improve lung function.
